Baker McKenzie advised Numab Therapeutics on the deal.Numab Therapeutics closed a CHF 100 million (approximately USD 110 million) Series C financing. Numab Therapeutics is a clinical stage…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
